RxDoctor Payments Data

Heidi Larison, DO

Family Medicine · Wichita, KSNPI 1447455662

Payments from drug & device makers

$6,126in general payments, 2019–2025

Across 409 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$1K
  • AbbVie$938
  • Lilly USA, LLC$799
  • AstraZeneca$477
  • Boehringer Ingelheim$345
  • Sanofi-aventis U.S. LLC$213
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$6,126100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$6,126 in reported general payments places this provider in the 90th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$97,270
Medicare patients
273
Services billed
24,471

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban101$75,357
OzempicSemaglutide49$48,745
MounjaroTirzepatide39$45,867
JardianceEmpagliflozin23$31,273
XareltoRivaroxaban20$31,182
JanuviaSitagliptin Phosphate23$27,648
TrulicityDulaglutide17$25,418
RexultiBrexpiprazole14$18,865
MyrbetriqMirabegron35$16,632
Soliqua 100-33Insulin Glargine/Lixisenatide20$14,814
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$14,484
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog13$13,813
FarxigaDapagliflozin Propanediol12$12,028
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog12$9,232
Fiasp FlextouchInsulin Aspart (Niacinamide)14$9,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Premarin$130$78,840114 claims
Lilly USA, LLCMounjaro, Trulicity$799$71,28656 claims
Novo NordiskOzempic$1,023$48,74549 claims
Boehringer IngelheimJardiance, Tradjenta$345$36,95334 claims
Johnson & JohnsonXarelto$181$31,18220 claims
MerckJanuvia$53$27,64823 claims
GSKTrelegy Ellipta, Arexvy$98$20,34938 claims
Otsuka America Pharmaceutical, Inc.Rexulti$39$18,86514 claims
Astellas Pharma US IncMyrbetriq$132$16,63235 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$213$14,81420 claims
AstraZenecaFarxiga$477$12,02812 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →